Docs
All documentation Fundamental API Live (Delayed) API EOD Historical API Intraday API Real-Time (websockets) API Google Sheets add-on Excel add-on
Community
Academy 134 articles Forum Github 13 repos
Marketplace
Spreadsheets
Google Sheets add-on Excel add-on Wordpress plugin
Pricing
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. NASDAQ /
  3. EVLO.NASDAQ

Evelo Biosciences Inc (EVLO NASDAQ) stock market data APIs

$0.0001 0(0%) as of July 26, 2024
Price chart is built with Anychart

Evelo Biosciences, Inc., a clinical-stage biotechnology company, focuses on discovering and developing oral medicines that act on immune cells in the small intestine with systemic effects. It is developing EDP1815, a whole-microbe product candidate, which has completed a Phase 2 trial for the treatment of psoriais; and is in Phase 2 clinical trial for the treatment of atopic dermatitis. The company is also developing EDP1867, a non-live pharmaceutical preparation for single strain of Veillonella parvula, which is in Phase 1b clinical trial; EDP2939, an investigational oral biologic for the potential treatment of inflammatory diseases; and EDP1908, a product candidate for oncology. Evelo Biosciences, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.

Evelo Biosciences Inc Financial Data Overview

0.0001
0.0001
-
0.0001
0.0001
0.0001-13.93
1 898
18 983 K
0
1.594
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'EVLO',
Type: 'Common Stock',
Name: 'Evelo Biosciences Inc',
Exchange: 'PINK',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG00H43XR69',
ISIN: NULL,
CUSIP: NULL,
CIK: '1694665',
EmployerIdNumber: '46-5594527',
FiscalYearEnd: 'December',
IPODate: '2018-05-09',
InternationalDomestic: 'Domestic',
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: 'Domestic',
IsDelisted: false,
}

Evelo Biosciences Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 0
  • EBITDA -69 674 000
  • Earnings Per Share -15.64
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get Evelo Biosciences Inc Earnings via APIs

  • Latest Release 2024-07-25
  • EPS/Forecast NaN

Get Evelo Biosciences Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Evelo Biosciences Inc latest news via APIs

Horizon Technology Finance Corporation (NASDAQ:HRZN) Q3 2023 Earnings Call Transcript

Horizon Technology Finance Corporation (NASDAQ:HRZN) Q3 2023 Earnings Call Transcript November 1, 2023 Operator: Greetings, and welcome to Horizon Technology Finance Corporation Third Quarter 2023 Ea...

Q3 2023 Horizon Technology Finance Corp Earnings Call

Participants Daniel Raffaele Trolio; Executive VP, CFO & Treasurer; Horizon Technology Finance Corporation Gerald A. Michaud; President & Director; Horizon Technology Finance Corporation Megan N. B...
Do you have any questions?
support@eodhistoricaldata.com